Atividade antimalárica, espectro e mecanismo de ação de compostos de rutênio e platina com a cloroquina / Antimalarial activity, spectrum and mechanism of action of ruthenium and platinum compounds with chloroquine

INTRODUÇÃO: A malária é uma das doenças infecciosas de maior incidência e que mais leva a óbito no mundo. Os medicamentos disponíveis são capazes de combater o parasita no ciclo intraeritrocítico, no entanto há cepas resistentes ao tratamento com quinolinas e temisininas. Além disso, os medicamentos em uso clínico não eliminam as formas sexuadas do parasita, responsáveis pela transmissão, nem os hipnozoítos, fase hepática latente causadora das recidivas da doença. Em virtude disso, é necessário identificar novos fármacos antimaláricos. Dentre as classes de moléculas com potencial terapêutico antimalárico, os complexos com metais de transição se destacam como possíveis candidatos...

The Plasmodium bottleneck: malaria parasite losses in the mosquito vector

Nearly one million people are killed every year by the malaria parasite Plasmodium. Although the disease-causing forms of the parasite exist only in the human blood, mosquitoes of the genus Anopheles are the obligate vector for transmission. Here, we review the parasite life cycle in the vector and highlight the human and mosquito contributions that limit malaria parasite development in the mosquito host. We address parasite killing in its mosquito host and bottlenecks in parasite numbers that might guide intervention strategies to prevent transmission.

Surface-expressed enolases of Plasmodium and other pathogens

Enolase is the eighth enzyme in the glycolytic pathway, a reaction that generates ATP from phosphoenol pyruvate in cytosolic compartments. Enolase is essential, especially for organisms devoid of the Krebs cycle that depend solely on glycolysis for energy. Interestingly, enolase appears to serve a separate function in some organisms, in that it is also exported to the cell surface via a poorly understood mechanism. In these organisms, surface enolase assists in the invasion of their host cells by binding plasminogen, an abundant plasma protease precursor. Binding is mediated by the interaction between a lysine motif of enolase with Kringle domains of plasminogen. The bound plasminogen is then cleaved by specific proteases to generate active plasmin. Plasmin is a potent serine protease that is thought to function in the degradation of the extracellular matrix surrounding the targeted host cell, thereby facilitating pathogen invasion. Recent work revealed that the malaria parasite Plasmodium also expresses surface enolase, and that this feature may be essential for completion of its life cycle. The therapeutic potential of targeting surface enolases of pathogens is discussed.

Análisis proteómico de Plasmodium, el agente causal de la malaria / Proteomic analysis of Plasmodium, the causal agent of Malaria

Los plasmodios son protozoarios cuyo complejo ciclo de vida se lleva a cabo en dos hospederos, el vertebrado y el mosquito. La infección de los seres humanos produce la enfermedad conocida como malaria. La secuenciación del genoma de Plasmodium falciparum y el desarrollo de la proteómica han permitido un gran avance en el conocimiento de la biología de este letal parásito. La presente revisión se centra en describir los logros recientes en el estudio del proteoma de Plasmodium falciparum y algunas de las implicaciones en la búsqueda de nuevos fármacos antimaláricos, así como en la generación de vacunas para el control de la enfermedad.

Plasmodia are protozoa whose complex life cycle takes place in two different hosts, the vertebrate and the mosquito. The human infection produces the malaria disease. The genome sequence of Plasmodium falciparum and the proteomic tools have enabled a huge advance in knowledge of the biology of this parasite. This review will focus on the recent advances in proteomic studies of Plasmodium falciparum and some implications for the search of new antimalarial drugs as well as vaccines for the control of the disease.

How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations.

Models occupy a key position in the development of anti-parasitic vaccines, yet their relevance has been seldom addressed. It is customary to admit that malaria vaccine development requires easy-to-handle, laboratory models. Animal models involving predominantly inbred rodents and primates as parasite hosts are currently the basic tools for the study of host-parasite interactions. Literature however indicates that the induction of host protection is more difficult in natural host-parasite pairs than in experimental models of parasite infection. Moreover different models delineate a wide range of host-pathogen relationship profiles providing a mosaic of contradictory informations, yet there is little incentive to delineate their relevance or to exploit recent advances to develop improved model systems. In this context the analysis of natural host-parasite interactions between Plasmodium berghei and its mammalian host and reservoir, the tree rat Grammomys surdaster could ge of relevance in the study of host-parasite interactions.

Interrupting malaria transmission by genetic manipulation of anopheline mosquitoes.

Malaria ranks among the deadliest infectious diseases that kills more than one million persons every year. The mosquito is an obligatory vector for malaria transmission. In the mosquito, Plasmodium undergoes a complex series of developmental events that includes transformation into several distinct morphological forms and the crossing of two different epithelia--midgut and salivary gland. Circumstantial evidence suggests that crossing of the epithelia requires specific interactions between Plasmodium and epithelial surface molecules. By use of a phage display library we have identified a small peptide-SM1--that binds to the surfaces of the mosquito midgut and salivary glands. Transgenic Anopheles stephensi mosquitoes expressing a SM1 tetramer from a blood-inducible and gut-specific promoter are substantially impaired in their ability to sustain parasite development and transmission. A second effector gene, phospholipase A2, also impairs parasite transmission in transgenic mosquitoes. These findings have important implications for the development of new strategies for malaria control.

Malaria vaccine development: Various immunization regimens for efficient induction of protective anti-malaria immunity

A malária permanece como a maior causa de morbidade e mortalidade humana em todo o mundo, devido à inexist6encia de medidas de controle eficientes para esta infecçäo. Considera-se que a vacinaçäo pode ser um meio eficaz que complementará outras estratégias de prevençäo e controle desta doença no futuro. Embora a possibilidade de uma vacina contra a malária tenha sido demonstrada nos anos 70, o desenvolvimento de uma facina universalmente eficaz contra esta parasitose tem sido uma difícil tarefa devido a diversos problemas complexos. Um dos aspectos é a complexidade do ciclo de vida do parasita, o qual envolve diferentes estágios que possuem antígenos específicos. Muitos antígenos parasitários têm sido investigados como candidatos potenciais à vacinaçäo, e a busca continua, com antígenos adicionais, sendo recentemente indentificados e caracterizados. Alguns desses antígenos estágio-específicos säo capazes de induzir respostas imunoprotetoras celular e humoral no hospedeiro. Todavia, essas respostas imunoprotetoras säo geralmente restritas geneticamente, adicionando outra dificuldade ao desenvolvimento de uma vacina universalmente eficaz. Por fim, o antígeno estágio-específico deve ser introduzido no hospedeiro utilizando-se um sistema de liberaçäo que possa induzir eficientemente respostas protetoras contra os respectivos estágios. No presente trabalho, revemos as diversas tentativas visando a induçäo de imunidade protetora contra todos os estágios do parasita, levando em consideraçäo os aspectos mencionados acima, que säo os antígenos protetores estágio-específicos, as respostas imunoprotetoras do hospedeiro, e os sistemas de liberaçäo antigênica.

Killing of blood stage Plasmodium vinckei petteri by spleen macrophages through L-arginine dependent mechanism.

A series of experiments was carried out to investigate the involvement of the L-arginine-dependent effector mechanism (LADEM) in the killing of the blood stages of the rodent malaria parasite, Plasmodium vinckei petteri, by activated spleen macrophages in vitro. P.v.petteri-infected red blood cells were co-incubated with spleen macrophages from normal mice which had previously received 10(8) Mycobacterium bovis (BCG) 5 days earlier, in the presence of 0.1 microgram/ml LPS with and without 0.1 mM L-NMMA, an L-arginine analogue which inhibits LADEM, for 16 hours. The viability of the parasites was assessed according to their infectivity following inoculation into experimental mice. Incubation of parasites with spleen macrophages in the presence of LPS without L-NMMA reduced the parasite viability to about 3%. When L-NMMA was included in the culture, inhibition of parasite killing was observed, resulting in an increase of parasite viability to about 21%. These data provide evidence to suggest that spleen macrophages play an important role as effector cells in the immune mechanisms against P.v.petteri infection, and that the parasite killing of these cells, at least in part, was mediated by LADEM.

Incidencia de paludismo en la Maná, Provincia del Cotopaxi 1993-1995

Se realizó un estudio retrospectivo (1993-1995), en el área de la Maná en pacientes don Dg. de paludismo confirmado mediante examen de gota fresa, los resultados indican que el paludismo es una enfermedad endémica que se presenta sobre todo en los meses de febrero, marzo y abril, con predominio en el sexo masculino, durante las dos primeras décadas de la vida; el agente etiológico más frecuente es el plasmodium vivax. La frecuencia anual de casos ha disminuído significativamente de 1993-1995, no encontrándose causa precisa que los justifique...

On the current existence of a coccidial line of development in the malaria parasites: a theory

Most opinion favors the origin of the malaria parasites from a coccidial ancestor. It is assumed that whatever the process through which the coccidia differentiated into a Plasmodium this phenomenon very probably occured millions of year ago, and during that differentiation process the original coccidia vanished. Therefore it has never repeated. At the light of some experiments the existence, at the present time, of a coccidial cycle of development in the malaria parasites, is proposed. The conection routes and mechanisms through which the malaria parasite changes to a coccidial life, and the routes in reverse are exposed. Transmission of the malaria-coccidial forms is suggested

Plasmodium vinckei petteri: algunos aspectos de su esporogonia y esquizogonia exoeritrocitaria / Plasmodium vinckei petteri: some aspects of its sporogony and exoerythrocytic schizogony

Por medio de la infeccion experimental de Anopheles stephensi, a partir de ratones portadores de gametocitos de Plasmodium vinckei petteri, se realizo el estudio morfologico de la esporogonia, que compreende: la descripcion del ooquineto, la evolucion completa de los ooquistes y su transformacion final en esporozoitos. Estos fueron empleados mas tarde para infectar por via intravenosa nuevos ratones, a los que se realizo biopsias sucessivas, para el estudio de los esquizontes exoeritrociticos, cuya morfologia no difere de la de otras especies del grupo. Se determino la duracion minima del ciclo hepatico, que resulto ser de 61 horas. Estos datos, junto a otros que refieren las caracteristicas del ciclo hematico, ayudan a completar la informacion que se tiene sobre la especie, que la hacen recomendable para su utilizacion como modelo experimental en el estudio de la malaria humana.

The interaction between the malaria parasite and the red cell membrane.

The malaria parasite intimately interacts with the host red cell membrane throughout the cycle of invasion and intracellular development. Direct interaction between the merozoite surface and the red cell membrane involves specific binding between the surface components of both cells, which leads to the subsequent endocytotic process still incompletely understood. Intracellular development of the parasite is accompanied by various changes in the structure and function of red cell membrane components. Some changes may benefit parasite survival while others trigger host immune response. An understanding of both the direct interaction between the surface components of the parasite and the red cell during invasion, and the subsequent changes in the red cell membrane following invasion, should lead to better ways of controlling malaria.

Sporozoite-induced Plasmodium cynomolgi infections in captive born Macaca fascicularis.

Capability of captive born cynomolgus monkeys to substitute for rhesus in the Plasmodium cynomolgi radical curative antimalarial drug development model was examined. Eighteen monkeys divided into 3 groups were given standard or high doses of sporozoites intravenously. One group of 4 received 0.8 - 1.6 X 10(6) and a second group of 8 received 0.3 - 1.0 X 10(7) sporozoites. The third group of 6 was splenectomized and then received 3.0 - 4.0 X 10(6). The 2 groups of intact monkeys developed a persistent low level parasitemia; however, gametocyte production was poor. The splenectomized group developed a persistent parasitemia with a higher mean, which more closely resembled rhesus parasitemias. A high, post-patent leukocytosis consisting primarily of lymphocytes was observed in this group. Good gametocyte production resulted in the splenectomized group and oocysts were produced from all lots of Anopheles dirus which fed on them. Following clearance of blood forms, relapse potential was demonstrated in the 2 splenectomized monkeys tested. In this study the splenectomized captive born cynomolgus appeared to be capable of supplementing rhesus as an antimalarial drug testing model.